Senior insider sale
SYNDAX PHARMACEUTICALS INC — senior position signals high conviction
$581.0K
43.20K shares
What this filing means
PODLESAK DENNIS plans to sell 43.20K shares of SYNDAX PHARMACEUTICALS INC valued at approximately $581.0K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/14/2025ACC: 0001950047-25-005839
Director
Since Jun 2019
43.20K
Shares to sell
$581.0K
Approx. market value
43.20K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Exercise of Stock Options
Cash
8/14/2025
43.20KTotal acquired43.20K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/14/2025 | Exercise of Stock Options Cash | 43.20K | — |
| Total | 43.20K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
43.20K
Market value
$581.0K
8/14/2025
Total
Units
43.20K
Value
$581.0K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
8/14/2025 | 43.20K | $581.0K | NASDAQ | Planned |
| Total | 43.20K | $581.0K | ||